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Available online 15 December 2015One of the most promising alternatives to petroleum for the production of fuels and chemicals is bio-oil based
chemistry. Microbial oils are gaining importance because they can be engineered to accumulate lipids enriched
in desired fatty acids. These speciﬁc lipids are closer to the commercialized product, therefore reducing pollutants
and costly chemical steps. Yarrowia lipolytica is themost widely studied and engineered oleaginous yeast. Differ-
ent molecular and bioinformatics tools permit systems metabolic engineering strategies in this yeast, which can
produce usual and unusual fatty acids. Usual fatty acids, those usually found in triacylglycerol, accumulate
through the action of several pathways, such as fatty acid/triacylglycerol synthesis, transport and degradation.
Unusual fatty acids are enzymaticmodiﬁcations of usual fatty acids to produce compounds that are not naturally
synthetized in the host. Recently, the metabolic engineering of microorganisms has produced different unusual
fatty acids, such as building block ricinoleic acid and nutraceuticals such as conjugated linoleic acid or polyunsat-
urated fatty acids. Additionally, microbial sources are preferred hosts for the production of fatty acid-derived
compounds such as γ-decalactone, hexanal and dicarboxylic acids. The variety of lipids produced by oleaginous
microorganisms is expected to rise in the coming years to cope with the increasing demand.
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General concerns about climate change and the increasing search for
renewable sources of energy are boosting bio-lipids as promising alter-
natives to fossil fuels. Over the last few decades, the chemical industry
has been developing technology that uses oils and fats as renewable
sources of precursors in the synthesis of polymers, plasticizers, lubri-
cants, coatings, surfactants, drugs, and fuels, among others [1]. Normal-
ly, lipids are produced in animals, plants and microbes in the form of
triacylglycerols (TAGs), which are thereafter modiﬁed by chemical
processes such as oxidation, C–C bond-forming additions, metathesis
or C–H activation [2] to constitute the ﬁnal products.
Notably, in contrast to animals and plants, microorganisms can
be easily engineered and accepted by industry and society. The recent
developments in systems metabolic engineering—an emergent disci-
pline that combines synthetic and systems biology and metabolic
modeling with traditional metabolic, genetic and protein engineering
techniques—facilitates the modiﬁcation of microorganisms to directly
produce unusual fatty acids. These unusual fatty acids are one step clos-
er to the ﬁnal product, thus reducing or completely avoiding chemical
processes during the manufacture [1].
In the recent years, the bio-based production of unusual fatty acids
has attracted signiﬁcant attention in both plants [3] and microbial
sources (see below).
Some microorganisms, called ‘oleaginous microorganisms’, are
able to accumulate high amounts of usual lipids (more than 20% of
their cell dry weight), and they are considered themost suitable chassis
for bio-oil production. Nonetheless, several approaches have been
employed to convert model organisms into oleaginous organisms by
genetic engineering. For example, E. coli has been extensively used to
produce free fatty acids [4], S. cerevisiae has been engineered to be
able to accumulate up to 50% of its DCW as lipids [5], and A. gossypii
modiﬁed to harbor genes from oleaginous organisms was able to accu-
mulate up to 70% of lipids [6].
Among oleaginous microorganisms, Yarrowia lipolytica is the most
studied due to both its interesting biotechnological characteristics and
its suitability to be manipulated in the laboratory. Here, we review the
lipid metabolism of Y. lipolytica, the latest advances and techniques in
its manipulation and the different approaches employed in recent
years to produce unusual fatty acids.
2. Yarrowia lipolytica: an industrial yeast
Yarrowia lipolytica is a dimorphic, non-pathogenic ascomycetous
yeast. It is often found in environments with the presence of hydropho-
bic substrates such as dairy products and oily waste. Therefore, several
strains have been isolated in soils contaminatedwith oils, in marine en-
vironments, in sediment samples and in waste waters [7]. Importantly,
the safety of this yeast has recently been assessed [8] because food sup-
plements have recently been approved for commercialization [9]. This
safety approval is particularly important for broadening the range of
possible applications of the products derived from the fermentation of
Yarrowia lipolytica.
The safety status ofYarrowia lipolytica and its uniquephysiological fea-
tures, such as the growth in hydrophobic substrates, has made it an im-
portant biotechnological yeast. Yarrowia lipolytica has been used for
many food-related applications [10], such as the production of meat and
dairy products, the production of aromas such as gamma decalactone,
the synthesis of organic acids (citric, isocitric, alpha-ketoglutaric, pyruvic
and succinic), spoilage yeasts for discoloration, the production of polyal-
cohol for sucrose replacement, the production of emulsiﬁers and surfac-
tants and the production of single cell oils and proteins for food. It hasalso been proposed for the treatment and degradation of pollutants [7]
such as hydrocarbons, oils, nitro, halogenated and organophosphate com-
pounds, for the reduction of metals and for the treatment of wastewater.
Additionally, it is an advantageous host for the production of
proteins, and more than 130 different proteins with academic or com-
mercial applications have been produced in this yeast [11].
Finally, as we introduce above and describe below, Yarrowia
lipolytica has been widely used in the production of lipids and lipid-
derived compounds [12] such as biodiesel, edible oils or dicarboxylic
acids as building blocks for polymers.
3. Systems metabolic engineering tools
The huge number of industrial applications has boosted both basic
research to understand the physiological features of Y. lipolytica and
the development of metabolic engineering tools. The genome of this
yeast (strain W9, CLIB122) has been sequenced [13] and manually an-
notated by a network of expert curators in the program Génolevures
[14]. Additionally, the genome of the strain Po1f, commonly used in
metabolic engineering approaches, has also been recently sequenced
[15].
For decades, molecular biology techniques have been developed in
Y. lipolytica. It has been engineered to increase the efﬁciency of homol-
ogous recombination to improve the frequency of the transformation,
which has facilitated gene overexpression and deletion [16]. Examples
of molecular biology tools developed in this yeast are replicative plas-
mids, constructions for genomic insertions, constitutive and inducible
promoters, ﬂorescence tags, protein expression and secretion vectors.
A recent review covering the topic was published by Madzak [17].
These molecular biology tools, alongwith systems biology, synthetic bi-
ology andmathematicalmodels, permit systemsmetabolic engineering,
which is currently boosting industrial biotechnology [18].
Genome scalemetabolicmodels (GEMs) have been shown to beuse-
ful tools in both basic and applied research [19]. Accordingly, they help
in the re-annotation of genomes and metabolic network analysis, and
they also permit the identiﬁcation of non-obvious targets for metabolic
engineering. In recent years, three genome-scale metabolic models of
Y. lipolytica have been developed [20–22], although none of them has
yet been used in metabolic engineering approaches.
Synthetic biology has been deﬁned as ‘the design and construction of
new biological systems (e.g., genetic control systems, metabolic path-
ways, chromosomes, cells) that do not exist in nature through the as-
sembly of well-characterized, standardized, reusable components’
[23]. Therefore, novel tools must be developed to facilitate and to
increase the complexity of synthetic systems. In Yarrowia lipolytica,
a method for the one-step integration of multiple genes has been
established [24]. Additionally, synthetic terminators [25] and plasmids
have been developed for increased expression levels and copy numbers
[26] and hybrid synthetic promoters [27,28]. In recent years, the
CRISPR-Cas9 system, a tool for genomeengineering, has been developed
and shown to be useful for manipulating a wide range of organisms, in-
cluding yeasts [29,30]. This technology has not yet been fully imple-
mented in Yarrowia, but this is expected to change in the near future
[31].
High-throughput technologies have enabled the analysis of
large amount of omics data for investigating cellular metabolism and
physiology at the systems level [32]. These systems biology data have
recently been obtained and analyzed for Y. lipolytica. In this regard,
transcriptomic analysis revealed four different transcription proﬁles
over 32 h of fermentation and identiﬁed genes potentially involved in
the metabolism of oleaginous species [33]. Additionally, transcriptomic
and proteomic analyses of Y. lipolytica have been conducted in relation
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Proteomic analysis was performed to study the proteins involved in the
transition yeast hyphae [35] and in the osmotic response to erythritol
[36]. Finally, ﬂuxomics in this yeast has been developed through meta-
bolic ﬂux analysis (MFA)with C13 [37,38]. Notably, metabolic ﬂux anal-
ysis has recently revealed the pentose phosphate pathway as the major
source of the cofactor required for lipid production [39]. Very recently,
metabolomics and lipidomics studies have revealed cell-wall biogenesis
proteins as possible targets to increase lipid accumulation [40].
All the cutting-edge technologies described above set the basis for
systems metabolic engineering approaches in Y. lipolytica, which is ex-
pected to boost the current limitation in lipid production, to enhance
yields and productivity and to improve the synthesis of unusual fatty
acids.
4. Lipid metabolism in Yarrowia lipolytica: from basic knowledge to
usual lipid production
The importance of Y. lipolytica as a biolipid producer has made it a
unicellular model organism to study fatty acid metabolism and lipid
accumulation. Here, we summarize the most important process and
genes involved in usual lipid synthesis and degradation (summarized
in Fig. 1). We here deﬁne usual lipids as those that are naturally and
abundantly synthesized by yeast and can be accumulated and stored
(such as triacylglycerols or steryl esters).
4.1. Fatty acid synthesis
Fatty acids are produced in the cytosol of Yarrowia from the building
block acetyl-CoA, which can come from ACS genes (acetyl-CoA synthe-
tase, YALI0F05962g), a pyruvate dehydrogenase complex, an amino
acid degradation pathway or ACL genes (ATP citrate lyase YALI0E34793g
and YALI0D24431g) [41]. ACL genes are present only in the genome ofFig. 1. Lipid metabolism in Y. lipolytica. Schematic representation of the metabolic pathways l
either glucose or free fatty acids (FFA). Dashed lines indicate multiple steps. DHAP (dihydroxy
CoA), PL (phospholipid), DAG (diacylglycerol). Gene names in italics are detailed in the text, i
metabolic pathways, as divided in the text: In red fatty acid synthesis and elongation and desa
blue fatty acid activation and transport, and in purple fatty acid degradation. The different org
reticulum, LB the lipid body and P the peroxisome.oleaginous yeast. Despite their overexpression [42] or heterologous
expression [43], they produce no increase or a slight increase in lipid con-
tent, and they have been considered a hallmark of oleaginous microor-
ganisms [44]. Y. lipolytica is able to use different carbon sources to
produce biomass and lipids, the most studied of which are glucose and
glycerol. Glycerol is a relevant and inexpensive industrial byproduct,
and it is therefore a desirable substrate for the industrial applications
of this yeast [45]. Nonetheless, glucose is still the most widely used in
lab-scale research. Recently, Y. lipolytica has been engineered to be able
to degradeother carbon sources, such as sucrose [46], fructose [47], galac-
tose [48], cellulose [49], cellobiose [50] or raw starch [51].
Acetyl-CoA carboxylase YALI0C11407g (ACC1) can transform acetyl-
CoA into malonyl-CoA. The overexpression of ACC1 has been associated
with lipid overproduction [52]. The fatty acid synthase (FAS) enzymatic
complex (YALI0B15059g and YALI0B19382g) produces acyl-CoA using
acetyl-CoA as an initiation molecule and malonyl-CoA as elongation
unit, adding two carbons to the fatty acid backbone.Most of the released
acyl-CoA corresponds to a chain length of 16 or 18 carbons. Thereafter,
these 16:0 and 18:0 activated molecules can be substrates of elongases
and desaturases. Elongases are responsible for chain elongation andwill
produce long chain fatty acids (YALI0B20196g) or very long chain fatty
acids (YALI0F06754g). Desaturases, located in the ER, produce either
a ﬁrst desaturation (OLE1; Δ9 desaturase, YALI0C05951g) to produce
palmitoleic (16:1) or oleic acid (18:1) or a second double bond
(Δ12desaturase FAD2, YALI0B10153g) to produce primarily linoleic
acid (18:2). Unexpectedly, the overexpression of OLE1 contributed to
an increased lipid yield in a previously engineered strain, producing
higher biomass titers and subsequently more fatty acids [53].
Alternatively, when Y. lipolytica grows in an oily environment, a
large battery of extracellular lipases produce fatty acids out of the oils,
which will be rapidly incorporated into the cell. In the cytosol, these
free fatty acids can be activated by FAA1 (fatty acyl-CoA synthetase,
YALI0D17864g) to produce acyl-CoA [54].eading to the production of neutral lipids (TAG, triacylglycerol and SE, steryl esters) from
acetone phosphate), G3P (glycerol-3-phosphate), AcCoA (acetyl-CoA), MaCoA (malonyl-
ncluding their functionality and Yarrowia name. The colors of the genes indicate different
turation system, in green triacylglycerol synthesis, in orange lipid remobilization, in light
anelles are indicated by the dark blue letters where N is the nucleus, ER the endoplasmic
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Y. lipolytica accumulates lipids in an intracellular particle called a
lipid body. It is primarily formed of neutral lipids, particularly TAGs
(85%) and some SE (8%) [55]. TAGs are formed through the Kennedy
pathway, where preformed DAG is converted into TAG either from
phospholipid by LRO1 (phospholipid:diacylglycerol acyltransferase,
YALI0E16797g) or from acyl-CoA by DGA1 and DGA2 (YALI0E32769g/
YALI0D07986g, respectively). SEs are formed from acyl-CoA, and sterol
is formed by ARE1 (YALI0F06578g) [56,57]. These reactions may take
place between the ER and the lipid body surface, where the responsible
enzymes have been found [55].Metabolic engineering approaches over-
expressingDGA1 andDGA2have successfully improved lipid production
[52,56,58,59]. This effect can be associated with the faster depletion of
cytosolic acyl-CoA, which is a well-known negative regulator of fatty
acid synthesis [60,61].
4.3. Lipid remobilization
Lipid bodies are dynamic structures that represent an additional car-
bon source once the nutrients of the media have been depleted. There-
fore, TAGs are substrates of intracellular lipases, which will release free
fatty acids at the surface of the lipid bodies. In Y. lipolytica, in contrast to
S. cerevisiae, there are two genes: TGL4 (YALI0F10010g), an active lipase
localized in the interface of the lipid body, and TGL3 (YALI0D17534g), a
positive regulator of TGL4. Notably, the spatial organization of these two
enzymes varies depending on the media composition and the physio-
logical state of the cell, suggesting a complex regulation. Importantly,
from a biotechnological point of view, the single or double deletion
of these genes results in a two-fold increase in the lipid-accumulation
capacity [62].
4.4. FA transport and activation
Free fatty acids, from either the extracellular media or TGL genes,
must subsequently be activated and transported to the peroxisome to
carry out beta-oxidation. Recently, a model for fatty acid transport and
activation has been proposed [54]. According to the model, free fatty
acids can 1) enter the peroxisome directly by unknown transporters
or be activated by FAA1 to acyl-coA, which can be 2) stored in lipid bod-
ies, as mentioned in the triacylglycerol synthesis section, or 3) enter the
peroxisome in an activated form through the speciﬁc transporters
Pxa1/Pxa2 (YALI0A06655g/YALI0D04246g). Free fatty acids in theFig. 2. Chemical structure of the unusual fatty acids produced in Y. lipolytica. Scheme of the chem
in Y. lipolytica and described in the text.peroxisome must be activated to be usable by the beta-oxidation en-
zymes. The AAL genes control this activation process (Dulermo R, man-
uscript under submission). However, AAL activation requires ATP,
which enters the peroxisome through the ANT1 protein (encoded by
YALI0E03058g). The model also suggests an alternative remobilization
pathwaymediated by FAT1 [63] (YALI0E16016g) that can directly trans-
port FA from the lipid body to the peroxisome. Notably, alternative
pathways show different chain-length preferences.4.5. Fatty acid degradation
Fatty acid degradation takes place in the peroxisome following the
beta-oxidation pathway, which is a four-reaction cycle resulting in
two carbon shortenings of the fatty acid backbone, accompanied by
the release of one molecule of acetyl-CoA. In Y. lipolytica, the ﬁrst step
is carried out by six acyl-CoA oxidase POX genes (YALI0E32835g,
YALI0F10857g, YALI0D24750g, YALI0E27654g, YALI0C23859g and
YALI0E06567g). The POX genes show different chain-length prefer-
ences, and the sextuple knockout strain is unable to degrade fatty
acids, which leads to a lipid over-accumulation phenotype [64–66].
The second and third steps in beta-oxidation are catalyzed by the multi-
functional enzyme MFE (YALI0E15378g), which, in contrast to POX, is
encoded by a single gene. The deletion ofMFE has been extensively stud-
ied in engineered strains for lipid production due to its technical simplic-
ity compared to POX1-6deletions [58,67]. The fourth and last step in beta-
oxidation is carried out by the thiolase POT1 (YALI0E18568g). Because
beta-oxidation takes place in the peroxisome, several strategies to block
this pathway address the abolition of peroxisome biogenesis through
the deletion of PEX3, PEX10 [68] and PEX11 [69].5. Unusual fatty acid production in Yarrowia lipolytica
5.1. Conjugated linoleic acid (CLA)
Conjugated linoleic acid is a group of octadecadienoic acids isomers
of linoleic acid (18:2, n9, n12) (Fig. 2). They are functional food, and
therefore, they are used as dietary supplement ingredients. The poten-
tial beneﬁts of CLA are the prevention of metabolic diseases and cancer,
anti-atherogenic and anti-obesity effects, and immune-systemmodula-
tion [70]. Most of these effects have been associated with two isomers:
cis-9, trans-11 CLA and trans-10, cis-12 CLA [71,72].ical structure of themost relevant fatty acids and fatty acid-derived compounds produced
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and dairy products. They are produced by probiotic microorganisms,
which use the linoleic acid present in milk [73].
CLAs have been chemically produced by the alkaline isomerization of
LApresent in plant oils [74]. However, this process generates amixture of
different CLAs, which is undesirable for medical and nutritional require-
ments. Therefore, microbiological synthesis represents a feasible alterna-
tive to produce speciﬁc isomers. In this regard, the bioconversions of
ricinoleic acid into a mixture of CLAs (cis-9, trans-11 and trans-9, trans-
11 octadecadienoic acids) were studied using Lactobacillus planetarium,
which produced up to 2.7 mg/ml of CLAs from 30 mg/ml of castor oil
[75,76]. More recently, the speciﬁc production of cis-9, trans-11
octadecadienoic acid (10.5 mg/mL) was achieved using Delacroixia
coronata and trans-vaccenic acid as substrates (33.3 mg/ml) [77]. Nomi-
croorganismwas found innaturewith a sufﬁcient bioconversion capacity
to produce high amounts of trans-10, cis-12-CLA.
Different isomerases have been characterized: one trans-10, cis-12
CLA-producing isomerase from Propionibacterium acnes and two from
cis-9, trans-11 CLA-producing isomerases from Clostridium sporogenes
and Lactobacillus reuteri [78,79]. These ﬁndings have boosted metabolic
engineering approaches to producing trans-10, cis-12-CLA in industrial
friendly strains by the heterologous expression of these enzymes.
Therefore, codon-optimized isomerase from Propionibacterium acnes
has been expressed in S. cerevisiae and tobacco plants, where CLA pro-
duction rose up to 5.7% and 15% of total free fatty acids, respectively
[80]. A similar approach has been developed in rice to produce up to
1.3% of total fatty acids in seeds [81]. Additionally, bioconversions of
LA into CLA were conducted when the same isomerase was expressed
in E. coli and Lactococcus lactis, with transformation rates of 50% and
30%, respectively [82].
Recently, metabolic engineering efforts have focused in the oleagi-
nous yeast Yarrowia lipolytica, which is able to cope with high amounts
of free fatty acids, the substrates of isomerases. In 2012, Zhang et al.
[83] expressed in high copy number a codon-optimized version of
Propionibacterium acnes in Y. lipolytica Polh, which produced trans-10,
cis-12-CLA with up to 5,6% of total fatty acids (0.23% of DCW) in the
neosynthesis condition from glucose. Additionally, the best strain was
able to show, in a biotransformation condition from linoleic acid, an
80% conversion rate of LA into CLA. Nonetheless, this strain was unsta-
ble, and the yield of CLA gradually decreased to 0.08% of DCW. One
year later, the same authors generated one improved strain of
Y. lipolytica able to produce CLA with up to 10% of total fatty acids
(0.4% of DCW) [84]. The same strain was able to produce 4 g/L of CLAFig. 3.Metabolic engineering strategy to produce CLA inY. lipolytica. PL, phospholipid;Ma,
Mortierella alpina; Yali, Yarrowia lipolytica; Pa, Propionibacterium acnes. Dashed lines
indicatemultiple enzymatic reactions. The purple line indicates the heterologous reaction.
The different organelles are indicated by the dark blue letters where ER is the endoplasmic
reticulum and LB the lipid body.from soybeanoil-basedmedia (44%of total fatty acids,which represent-
ed 30% of DCW). In this approach, the codon-optimized isomerase was
coexpressed with a Δ12 desaturase from Mortierella alpina under the
control of a modiﬁed promoter, hp4d, fused to 12 additional copies of
UAS1B. A multi-copy integration plasmid was used to further enhance
the expression of both genes. Therefore, the resulting Y. lipolytica strain
is a promising candidate platform to produce trans-10, cis-12-CLA.
Schematic Fig. 3 represents themetabolic engineering approach carried
out in Y. lipolytica to produce CLA.5.2. Ricinoleic acid (RA)
Ricinoleic acid (RA; 12-hydroxy-octadeca-cis-9-enoic acid: C18:1-
OH) is a hydroxylated unusual fatty acid that can be exploited in several
industrial applications (Fig. 2). RA is considered a renewable material
for the chemical industry, which can use it as a substrate for double-
bond reactions (oxidation, polymerization, hydrogenation, epoxidation,
halogenation, addition reactions, sulfonation and metathesis) and for
hydroxyl-group reactions (dehydration, hydrolysis, caustic fusion, py-
rolysis, alkoxylation, esteriﬁcation, halogenation, urethane formation
and sulfonation) [85]. Its derivatives can be used as plasticizers, lubri-
cants, dyes, inks, soaps, adhesives, pharmaceuticals, paints, food addi-
tives, textiles, paper, electronic components, perfumes, cosmetics and
biofuels [86,87].
The major source of RA is castor oil, extracted from the seeds of the
castor plant (Ricinus communis). RA represents 90% of the total fatty
acids of seed oil. However, the castor plant is not a suitable crop for a va-
riety of reasons: 1) Its cultivation is limited to tropical and subtropical
regions. 2) It is primarily produced in areas with economic and political
instability, which produces ﬂuctuations in price and supply. 3) The
seeds must be harvested by hand, which is not convenient for large-
scale production. 4) The seeds contain ricin, a toxic protein that causes
health problems to workers. Finally, 5) the reﬁning process is long and
tedious and includes many steps, such as removing undesired colors,
odors, ﬂavors and ricin.
Therefore, the increasing number of potential applications of RA and
the drawbacks associated with its traditional production have pushed
the scientiﬁc community to ﬁnd alternative sources of this unusual
fatty acid.
The molecular mechanisms involved in RA biosynthesis are known,
which has permitted the development of metabolic engineering ap-
proaches to producing fatty acids in other plants and microorganisms.
RA is formed in a reaction catalyzed by a Δ12-hydroxylase (FAH12),
which adds a hydroxyl group (−OH) to the 12th carbon of oleic acid
moieties [88] esteriﬁed to the sn-2 position of primarily phosphatidyl-
choline in the endoplasmic reticulum membrane [89]. This FAH12 has
been heterologously expressed in tobacco [90], where low levels of RA
were produced (b1%), and in the model plant Arabidopsis thaliana,
which produced RA up to 20% of total fatty acids when the endogenous
Δ12-desaturase (which competes for the substrate) was deleted
[91–94]. These production titers were increased to 30% of total fatty
acids when RcDGAT2 (Ricinus communis diacylglycerol acyltransferase)
was coexpressed with R. communis FAH12 in A. thaliana [95,96]. None-
theless, these levels remain far lower than those in the native castor
seeds.
Alternatively, the production of RA in microorganisms has been
studied both in model organisms such as S. cerevisiae and S. pombe
and in the oleaginous yeast Y. lipolytica. Baker's yeast has been used to
express RcFAH12 under the control of GAL10, but only 0.8% of total
fatty acids were RA [92].
More recently, Meesapyodsuk and Qiu [97] isolated the ﬁrst non-
plant Δ12-oleate hydroxylase from the sclerotium tissue of the fungus
C. purpurea (CpFAH12). Its expression in S. cerevisiae under a GAL1 pro-
moter produced up to 19% of RA when the cells were grown in oleate
media. The co-expression of CpFAH12 with the fungal diacylglycerol
45R. Ledesma-Amaro, J.-M. Nicaud / Progress in Lipid Research 61 (2016) 40–50acyltransferase CpDGAT2 also increased by approximately 30% the total
production of RA content [98].
In contrast to S. cerevisiae, S. pombe produces oleic acid approximate-
ly 75% of total fatty acids, whichmake it amore appropriate organism to
produce RA de novo. Holic and colleagues [99] expressed CpFAH12
in S. pombe and produced 52.6% of RA, a total of 137.4 μg/ml. Notably,
RA showed a toxic effect with associated growth defects at 30 °C,
which were completely solved at 37 °C. Thus, their strategy included a
ﬁrst growth phase at 37 °C, followed by a production phase at 20 °C.
The RA content was further improved 1.98-fold after the deletion of
the three triglyceride lipases (TG lipases Tgl3, TGl4 and Tgl5) involved
in storage-lipid remobilization [100]. Later, Yazawa et al. [101] found
in a cDNA library from S. Pombe that PGL7, which encodes for a phospho-
lipase A2, restored growth defects after the expression of CpFAH12. It is
speculated that this lipase activity may remove RA from phospholipids,
suppressing its toxicity. This same strain was able to secrete up to
approximately ~185 μg/ml, and the intracellular amount remained the
same (~200 μg/ml), thus improving the total production titer [102]. Fi-
nally, the overexpression of PTL2, one of the intracellular TG lipases that
also showedphospholipase activity, increased the secreted and intracel-
lular RA levels by 1.2- and 1.3-fold, respectively [103].
Despite the above-mentioned enhancement of the production of RA
in S. pombe, the lipid-accumulation capacity of this yeast, which is typi-
cally approximately 5% of the DCW, limits its use as a substitute of castor
oil. Therefore, microorganisms with the ability to accumulate high
amounts of lipids have to be considered. In this regard, Y. lipolytica,
which is awell-known oleaginous yeast that accumulates high amounts
of oleic acid, has been regarded as the most suitable candidate for RA
production.
In 2013, Beopoulos et al. [104] constructed a multiple engineered
strain that could accumulate RA up to 43% of its total lipids and
more than 60 mg/g of DCW. This strain was unable to perform beta-
oxidation due to the deletion of the six POX genes blocking the
β-oxidation pathway, which permits a higher lipid accumulation. Addi-
tionally, the endogenous Δ12-desaturase (FAD2 gene) was deleted to
avoid competition by the substrate oleic acid. Moreover, the strain
was deleted for three DAG acyltransferases (DGA1, DGA2 and LRO1)
and overexpressed for Lro1p, rerouting TAG synthesis only through
phospholipids. In this case, the best production of RA was found with
the expression of two copies of CpFAH12, whereas slight RA production
was shownwith RcFAH12 instead, and RA reduction took place after the
co-expression of RcDGAT2 or CpDGAT2. This best producer strain was
further improved by the expression of three copies of CpFAH12 andFig. 4.Metabolic engineering strategy to produceRA inY. lipolytica. ×2 or×3, twoor three
copies of the gene were overexpressed. PL, phospholipid. Dashed lines indicate multiple
enzymatic reactions. Red crosses indicate deleted reactions. The purple line indicates the
heterologous reaction. The different organelles are indicated by the dark blue letters
where ER is the endoplasmic reticulum, LB the lipid body and P the peroxisome.two copies of LRO1 [105]. When this strain was cultured in a 10-L biore-
actor using a deﬁnedmediumwith 160 g/L of glucose and 24 g/L of oleic
acid, it produced 12 g/L of RA, which represented 60% of total lipids.
Schematic Fig. 4 represents the metabolic engineering approach
employed in Y. lipolytica to produce RA.
5.3. Polyunsaturated fatty acids: EPA and DHA
Over the last fewdecades, polyunsaturated fatty acids (PUFAs), partic-
ularly eicosapentaenoic acid (EPA; 20:5Δ5,8,11,14,17) and docosahexaenoic
acid (DHA; DHA, 22:6Δ4,7,10,13,16,19), have attracted scientiﬁc attention
because they have been associated with several health beneﬁts (Fig. 2).
They are essential for proper visual and neurological development, they
reduce the incidence of cardiovascular diseases, and they prevent myo-
cardial infarction, bronchial asthma, inﬂammatory bowel disease, major
depression and several types of cancer. A recent review has been pub-
lished on the positive effects of EPA and DHA on human health [106].
Humans and mammals are not able to synthetize these omega-3 fatty
acids de novo, so we need to uptake them from our diets. Although
humans are able to produce EPA and DHA from exogenous LA and ALA,
the efﬁciency of the conversion is very low. Therefore, the supplementary
intake of these omega-3 fatty acids has been recommended by several
health organizations [107].
Currently, the most important source of DHA and EPA is ﬁsh oils.
Fish acquire omega-3 fatty acids frommarinemicroorganisms and phy-
toplankton. Unfortunately, ﬁsh oils are not able to cope with the ever-
increasing global demand because of the decline of worldwide ﬁsh
stocks and the environmental pollution of marine ecosystems [108].
The search for alternatives has revealed two major candidates:
plants andmicrobial oils. Both plants andmicrobes must be engineered
to produce enough of the desired fatty acids. Several approaches have
succeeded in the generation of transgenic plants with oilseed enriched
in omega-3 fatty acids, although the desired yield and oil composition
have not yet been achieved [109]. Remarkably, as a proof of concept,
Ruiz-Lopez et al. generated a transgenic oilseed crop (Camelina sativa)
with ﬁsh oil-like levels of EPA and DHA [110].
In parallel, a vast number of studies have focused on the production
of EPA and DHA in microorganisms. Somemicroalgae (Crypthecodinium
cohnii and Schizochytrium sp.) are good producers of DHA, and a
few market products are already available. Nonetheless, difﬁculties in
large-scale cultivation often limit their applicability. For a comprehen-
sive review of microalgae omega-3, see [111].
Synthetic biology advances enable the heterologous expression of
omega-3 pathways in industrial-friendly microorganisms. Therefore,
different metabolic engineering approaches have been employed in a
wide range of microorganisms, which has been recently reviewed
[112]. The omega-3 pathway comprises a variety of desaturases and
elongaseswith different substrate speciﬁcities in chain length, the num-
ber of double bonds and lipid moiety.
Although signiﬁcant efforts have been made to express elongases
and desaturases in different microorganisms, such as S. cerevisiae
[113], Mortierella alpina [114] and Lipomyces starkeyi [115], the best
EPA producer to date is a modiﬁed Y. lipolytica strain [116]. This strain
was constructed by DuPont following a strategy hereafter summarized
(for more detailed information, the authors recommend the recent re-
views by Zhu et al. [116,117]). First, a screening over 40 Y. lipolytica
strains was revealed as the most suitable for lipid production of strain
(ATCC) #20362 with DCW greater than 100 g/L, a lipid content greater
than 30% DCW, and lipid productivity greater than 1 g/L/h. Second,
this strain was transformed with Δ6 desaturase, C18/20 elongase, Δ5
desaturase and Δ17 desaturase under the control of a TEF promoter,
which enables it to produce 3% of EPA through the Δ6 pathway. This
ﬁrst approach served as a proof of concept and as a way to identify the
bottlenecks of the pathway: 1) low ﬂux into the engineered pathway,
2) low efﬁciency of the elongase and 3) an insufﬁciently high expression
of the genes of the pathway. Accordingly, the approach improved the
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setting up a system of codon optimization and by developing an URA/
FOAmethod for multiple copy integration. To increase the ﬂux through
the Δ6 pathway, an elongase to produce stearic acid (18:0) from
palmitic acid (16:0) ofM. alpina [118] and aΔ12 desaturase from Fusar-
ium moniliforme [119] were overexpressed. This strain (Y9027) harbors
a total of 19 copies of different heterologous genes and is able to pro-
duce up to 40% of EPA [120]. However, this strain still accumulates up
to 21% of GLA, an undesired omega-6 fatty acid, suggesting a rate-
limiting acyl exchange between the phospholipid and CoA pools in the
ER membrane.
GLA is an omega-6 fatty acid that has been considered undesired in
omega-3 supplements. In fact, a low omega-6/omega-3 ratio has been
associated with several health beneﬁts [121]. To avoid the concomitant
production of GLA during EPA production, theΔ9 pathwaywas used in-
stead of the Δ6 pathway described above. The enzymes of the Δ9 path-
way are Δ9-elongases [122] and Δ8-desaturases [123]. Bifunctional
fusion genes of Δ9-elongase and Δ8-desaturase with increased activity
were developed [124]. Again, multiple copies of the selected codon-
optimized genes under strong promoters were integrated into the ge-
nome (Δ9-elongase, Δ8-desaturase, C16/18-elongase, Δ12-desaturase
gene, Δ17-desaturase, Δ5-desaturase and cholinephosphotransferase).
The casual integration of one of the constructions at the PEX10 locuswas
shown to be highly advantageous for EPA production. The ﬁrst generat-
ed strain Y4305 [9] contained 30 copies of 9 different genes and pro-
duced EPA at 56.6% FAMEs and approximately 15% DCW, without GLA
accumulation. This strain was further improved to generate Z1978
with a total of 35 copies of 17 different genes. Z1978 produced EPA at
N58% FAME and approximately 20% DCW [125]. On this, the best strain
was constructed and called Z5567, which contained 41 copies of 19 dif-
ferent genes, producing EPA at approximately 50% FAME and approxi-
mately 25% DCW [125].
Finally, the successful development and optimization of the fermen-
tation processes resulted in two commercial products, New Harvest™
EPA oil and Verlasso® salmon, using Y. lipolytica as source of EPA. Sche-
matic Fig. 5 represents themetabolic engineering approach employed in
Y. lipolytica to produce EPA.
5.4. Unusual compounds derived from fatty acids
Both usual and unusual fatty acids can serve as substrates for
enzymatic activities that convert them into industrial products. Here,
we summarize three of these industrial fatty acid-derived compoundsFig. 5.Metabolic engineering strategy to produce EPA in Y. lipolytica. Dashed lines indicate
multiple enzymatic reactions. The red cross indicates the deleted gene. The purple line in-
dicates the heterologous reaction. ARA, arachidonic acid. EPA, eicosapentaenoic acid. ELO,
elongase. DES, desaturase. The different organelles are indicated by the dark blue letters
where ER is the endoplasmic reticulum, LB the lipid body and P the peroxisome.that have been produced in Y. lipolytica: dicarboxylic acids (DCA; exten-
sively reviewed in [126]), which derive from usual fatty acids and
γ-decalactone (reviewed in [127]), and hexanal, which derive from un-
usual fatty acids. In contrast to the production of fatty acids, up to now in
these processes, lipids are added to themedia to serve as biotransforma-
tion sources. Nonetheless, advances in biolipid production from other
common carbon sources, such as glucose, or inexpensive ones, such as
lignocelluloses, are expected to lower the production costs in the com-
ing years.
5.4.1. γ-decalactone production
γ-decalactone is a natural peach aromawidely used in food and bev-
erages. Its biotechnological production has been studied with interest
(Fig. 2). The biosynthetic pathway of γ-decalactone begins with the hy-
droxylation of oleic acid to produce RA. This step is followed by four
rounds of beta-oxidation, which leads to the production of 4-hydroxy-
decanoic acid, the precursor of γ-decalactone. This precursor is thereaf-
ter isomerized and lactonizated to form the ﬁnal product. Y. lipolytica
has been widely studied in the biotransformation of exogenous RA or
castor oil into γ-decalactone [127]. This process was optimized by met-
abolic engineering approaches comprising combinatorial deletions in
the POX genes involved in the ﬁrst step of β-oxidation. Because each
of the six POX genes is known to have different chain-length speciﬁc-
ities, the deletion of short chain oxidase (POX3) increased the availabil-
ity of the precursor 4-hydroxy-decanoic acid and therefore total γ-
decalactone [128,129]. Additionally, the decrease in the activity in the
long-chain acyl-CoA oxidases resulted in higher γ-decalactone versus
3-hydroxy-γ-decalactone amounts [130]. 3-hydroxy-γ-decalactone
accumulates when NAD supply is not sufﬁcient, and thus, the ﬂux
reduction through β-oxidation permits a better supply of the required
cofactor to speciﬁcally produce γ-decalactone. The production of γ-
decalactone was further optimized by Belo et al. and other groups
who studied and optimized different types of fermentation [131,132],
parameters such as aeration and PH [133,134] and cell-immobilization
materials [135]. More recently, different rounds of UV irradiation and
genome shufﬂing modiﬁed Yarrowia strains, which were able to pro-
duce a 6.5-fold higher γ-decalactone than the wild type and a total
3.75 g/L [136]. This titer was further improved to 8 g/L through cell
immobilization in attapulgite along with the use of ionic liquid as a
cosolvent [137]. Efforts to decipher the complete synthetic pathway
along with novel metabolic engineering approaches may improve lac-
tone production by yeast in the next few years.
5.4.2. Hexanal production
Hexanal is a C-6 aldehyde, a green-notemolecule with characteristic
ﬂavors of fruits, vegetables and green leaves (Fig. 2) [138]. It is a high-
value product widely used by the aroma industry.
These fatty acid aldehydes are naturally produced by plants, which
synthetize them either from linoleic or linolenic acid in a two-step
pathway. First, fatty acids are converted by a lipoxygenase (LOX) into
13-hydroperoxides, which are thereafter transformed into hexanal or
trans-2-hexanal by a hydroperoxide lyase (HPL) [139]. The current
industrial production of these aldehydes relies on plant homogenates
as enzyme sources characterized by low enzyme concentration
and low speciﬁcity [140]. As an alternative, these enzymes have been
expressed in microbes, E. coli and yeasts. On the one hand, E. coli-
expressing HPL was able to produce hexanal up to 140 μg per 10 μl of
cell lysate [141]. One the other hand, S. cerevisiae was ﬁrst engineered
to express an HPL from banana and to produce cis-3-hexenal [142].
More recently, the co-expression of both HPL from watermelon and
LOX from soybean resulted in strains producing approximately
60 mg/L of 3-hexenal by the bioconversion of linoleic acid using resting
cells [140].
In Y. lipolytica, Bourel et al. [139] expressed an HPL from green bell
pepper. In this approach, a maximum production of C-6 aldehydes of
350 mg/L hexanal and 50 mg/L of trans-2-hexenal was reached when
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version from the ﬁrst hours to the maximum production peak, there
was a strong decrease in hexanal, likely due to the action of fatty alde-
hyde dehydrogenases. Although this strategy so far represents the
highest bioconversion rate using microbial systems, it is still far from
plan-based systems, and therefore, further improvements must be
made, such as the deletion of degrading reactions or the enhancement
of enzymatic activity. Additionally, the use of hydroperoxides as sub-
strates has been shown to be toxic for the cells due to its interactions
with the phospholipids of the membranes, which signiﬁcantly reduce
the efﬁciency of the conversion [143]. The co-expression of a LOX
enzyme in the Yarrowia strain expressing the HPL would allow for the
direct biotransformation from linoleic acid andnot from its hydroperox-
ide form, reducing its toxicity. In addition, this approach could boost en-
dogenous linoleic acid conversion into hexanal, which could therefore
be produced from cheaper carbon sources such as glycerol.
5.4.3. Dicarboxylic acids production
Dicarboxylic acids (DCA) are important building blocks for
bioplastics such as polyamide and polyester (Fig. 2). Currently, long-
chain DCA are primarily produced by a chemical process, although
eco-friendly biotechnological fermentation has been developed. Long-
chain DCA are produced by the functionalization of alkanes or fatty
acids via biooxidation. Brieﬂy, the omega terminal part of the fatty
acid is oxidized by the hydroxylase complex, formed by a Cytochrome
P450 monooxygenase and a NADPH-dependent Cytochrome P450 oxi-
doreductase. Then, the produced omega-hydroxy fatty acid is further
oxidized by a fatty alcohol oxidase into a fatty acid aldehyde. Finally,
DCA is synthetized by the action of a NAD-dependent fatty aldehyde
dehydrogenase. These DCA can thereafter be degraded via β-oxidation
in the peroxisome.
The biotransformation of alkanes or fatty acids into DCAwas ﬁrst re-
ported in C. tropicalis, where the deletion of two of the three POX genes
coding for the acyl-CoA oxidases was essential for a high accumulation
[144,145]. An increase of DCAwas also found after impairing the degra-
dation of fatty acids by the deletion of carnitine acetyl-transferase (CAT
gene) [146].
Another way to increase DCA yield is the overexpression of the en-
zymes of the pathway. Following this rationale, the co-expression of
CYP monooxygenase and reductase genes in C. tropicalis increased by
30% the total production of DCA [145].
Y. lipolytica is also capable of degrading alkanes and therefore of pro-
ducing DCA. Nicaud et al. [147] showed a higher production of DCA
when a higher number of POX genes was deleted. Further experiments
with taggedmutants identiﬁed interesting genes related to alkane utili-
zation, which could be potentially used in biotechnological approaches,
such as thioredoxin reductase, peroxines, succinate–fumarate carrier
and isocitrate lyase [148]. In the same manner as in C. tropicalis, the
overexpression of some of the CYP monooxygenases and the reductase
increased DCA production [149]. Recently, the enzyme responsible
for fatty alcohol oxidase (FAO) in Y. lipolytica was identiﬁed, and its
overexpression led to an increase in DCA production [150]. In spite of
the efforts to produce DCA in Y. lipolytica, the bioconversion titers are
not high enough to compete with C. tropicalis, and thus, further strain
development by metabolic engineering and bioreactor-optimization
approaches must be employed [126].
6. Conclusions and perspective
In the exhaustive search for alternatives to fossil fuels, oil-based
chemistry is gaining importance due to its similar properties and possi-
bilities. In particular, microbial oils are attracting considerable attention
because they are industrially and socially accepted and can be easily
adapted to market needs.
Among the lipid-producer microorganisms, Yarrowia lipolytica is the
most studied, with an extensive toolbox for metabolic engineering. Ithas been shown to be suitable for large-scale fermentations. The unusu-
al fatty acids are one step closer to the commercial product than the
usual lipids, which make them highly valuable products and more eco-
nomically viable. As reviewed in this article, metabolically engineered
Y. lipolytica is able to produce CLA, RA and EPA and has thus already
led to several commercialized products. The recent advances in systems
metabolic engineering along with the novel discovery of different en-
zymes involved in fatty acid modiﬁcation will broaden the range of un-
usual fatty acids produced by this yeast. Some of these potential
products are medium-chain fatty acids, double bond-end fatty acids,
other conjugated and hydroxyl fatty acids, and epoxy and acetylenic
fatty acids. Moreover, the development of novel synthetic biology tech-
niques alongwith the growing interest in an integrated view of the sys-
tem due to omics data will boost oleochemical production in oleaginous
yeasts. Synthetic biology tools may facilitate gene modiﬁcation and
speed up metabolic engineering approaches, saving both time and re-
sources. Systems biology may also help identify novel, non-obvious tar-
gets of manipulation to enhance lipogenesis. Additionally, fermentation
technologies, downstreamprocesses and upscaling from lab to industri-
al scales require more rigorous studies not only to control and to maxi-
mize yield but also to reduce competingundesired reactions, such as the
usual co-production of citric acid during lipid production.
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